Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SOLU-MEDROL | Pharmacia & Upjohn | N-011856 RX | 1982-01-01 | 5 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
depo-medrol | New Drug Application | 2025-08-28 |
dyural 40 kit | unapproved drug other | 2024-12-31 |
dyural 80 kit | unapproved drug other | 2024-12-31 |
dyural 80-lm | unapproved drug other | 2024-12-31 |
dyural l kit | unapproved drug other | 2024-10-05 |
dyural lm kit | unapproved drug other | 2024-10-05 |
hybrisil | unapproved drug other | 2011-04-22 |
medrol | New Drug Application | 2025-04-22 |
medroloan ii suik | unapproved drug other | 2022-12-09 |
medroloan suik | unapproved drug other | 2022-12-09 |
Code | Description |
---|---|
J1020 | Injection, methylprednisolone acetate, 20 mg |
J1030 | Injection, methylprednisolone acetate, 40 mg |
J1040 | Injection, methylprednisolone acetate, 80 mg |
J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg |
J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg |
J7509 | Methylprednisolone oral, per 4 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 36 | 100 | 53 | 4 | 14 | 182 |
Leukemia | D007938 | — | C95 | 17 | 75 | 23 | 7 | 9 | 116 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 10 | 45 | 25 | 9 | 6 | 84 |
Syndrome | D013577 | — | — | 8 | 35 | 15 | 12 | 19 | 82 |
Prostatic neoplasms | D011471 | — | C61 | 11 | 33 | 26 | 6 | 9 | 78 |
Covid-19 | D000086382 | — | U07.1 | 2 | 10 | 25 | 7 | 17 | 57 |
Kidney transplantation | D016030 | — | — | 5 | 19 | 14 | 20 | 3 | 56 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 3 | 17 | 16 | 15 | 5 | 55 |
Inflammation | D007249 | MP_0001845 | — | 3 | 8 | 15 | 14 | 15 | 52 |
Asthma | D001249 | EFO_0000270 | J45 | 2 | 8 | 10 | 15 | 15 | 49 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Graft vs host disease | D006086 | — | D89.81 | 16 | 37 | 16 | — | 7 | 68 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 15 | 46 | 14 | — | 2 | 66 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 12 | 37 | 17 | — | 5 | 63 |
Myelodysplastic syndromes | D009190 | — | D46 | 10 | 39 | 2 | — | 4 | 49 |
B-cell lymphoma | D016393 | — | — | 15 | 29 | 9 | — | 2 | 44 |
Plasma cell neoplasms | D054219 | — | — | 9 | 17 | 8 | — | 6 | 40 |
Preleukemia | D011289 | — | — | 4 | 22 | 2 | — | 3 | 27 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 5 | 18 | 3 | — | 1 | 25 |
Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 18 | 2 | — | 1 | 24 |
Alcoholic hepatitis | D006519 | EFO_1001345 | K70.1 | 1 | 6 | 9 | — | 7 | 22 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloproliferative disorders | D009196 | — | D47.1 | 5 | 17 | — | — | 2 | 22 |
Myelodysplastic-myeloproliferative diseases | D054437 | — | — | 1 | 11 | — | — | 2 | 14 |
Mantle-cell lymphoma | D020522 | — | C83.1 | 3 | 9 | — | — | 1 | 12 |
T-cell lymphoma | D016399 | — | — | 5 | 9 | — | — | — | 11 |
B-cell lymphoma marginal zone | D018442 | — | C88.4 | 3 | 8 | — | — | 1 | 11 |
Myeloid leukemia chronic-phase | D015466 | — | — | 2 | 8 | — | — | 1 | 10 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 3 | 7 | — | — | 1 | 10 |
T-cell lymphoma peripheral | D016411 | — | — | 4 | 8 | — | — | — | 9 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | 8 | — | — | — | 9 |
Myeloid leukemia accelerated phase | D015465 | — | — | 2 | 6 | — | — | 1 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pathologic dilatation | D004108 | — | — | 1 | — | — | — | 4 | 5 |
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | 1 | — | — | — | 3 | 4 |
Therapeutic equivalency | D013810 | — | — | 3 | — | — | — | — | 3 |
Precancerous conditions | D011230 | — | — | 2 | — | — | — | — | 2 |
Friedreich ataxia | D005621 | Orphanet_95 | G11.11 | 2 | — | — | — | — | 2 |
Retinal perforations | D012167 | EFO_1001028 | — | 1 | — | — | — | 1 | 2 |
Fever | D005334 | — | R50.9 | 1 | — | — | — | 1 | 2 |
Tinnitus | D014012 | — | H93.1 | 1 | — | — | — | 1 | 2 |
Laser therapy | D053685 | — | — | 1 | — | — | — | 1 | 2 |
Innate immunity | D007113 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Morton neuroma | D000070607 | — | G57.6 | — | — | — | — | 3 | 3 |
Rotator cuff injuries | D000070636 | — | M75.1 | — | — | — | — | 3 | 3 |
Regeneration | D012038 | — | — | — | — | — | — | 3 | 3 |
Mycoplasma infections | D009175 | — | — | — | — | — | — | 2 | 2 |
Pleuropneumonia | D011001 | — | — | — | — | — | — | 2 | 2 |
Keratoconjunctivitis | D007637 | — | H16.2 | — | — | — | — | 2 | 2 |
Cicatrix | D002921 | — | L90.5 | — | — | — | — | 2 | 2 |
Blood pressure | D001794 | EFO_0004325 | — | — | — | — | — | 2 | 2 |
Vitiligo | D014820 | EFO_0004208 | L80 | — | — | — | — | 2 | 2 |
Uveomeningoencephalitic syndrome | D014607 | Orphanet_3437 | H20.82 | — | — | — | — | 2 | 2 |
Drug common name | Methylprednisolone |
INN | methylprednisolone |
Description | 6alpha-methylprednisolone is the 6alpha-stereoisomer of 6-methylprednisolone. It has a role as an anti-inflammatory drug, a neuroprotective agent, an antiemetic, an adrenergic agent, a xenobiotic and an environmental contaminant. It is a 6-methylprednisolone, a primary alpha-hydroxy ketone and a tertiary alpha-hydroxy ketone. |
Classification | Small molecule |
Drug class | steroids (not prednisolone derivatives); prednisone and prednisolone derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12 |
PDB | — |
CAS-ID | 83-43-2 |
RxCUI | — |
ChEMBL ID | CHEMBL650 |
ChEBI ID | 6888 |
PubChem CID | 6741 |
DrugBank | DB00959 |
UNII ID | X4W7ZR7023 (ChemIDplus, GSRS) |